Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It wasn't a clerical error by conference. I just posted the email for conference manager stating author made revision. Now of course he could be just telling me this but...
According to ctad 2015 I believe there are 4 authors?
Steve Macfarlane, MD (1), Paul Maruff, PhD (2), Marco Cecchi, PhD (3), Dennis Moore, PhD (3), Anastasios
Zografidis, PhD (4), Christopher Missling, PhD (4)
(1) Caulfield Hospital, Melbourne, Australia; (2) Cogstate, Melbourne, Australia; (3) Neuronetrix, KY, USA; (4) Anavex Life Sciences, Corp., New York, NY, USA
Also ask qualifications for acceptance and he gave me the obvious answer but I will continue to find out more if possible.
Dear Sir,
A "late-breaker abstract" is an abstract that was submitted after September 1st, due to late results in clinical trials, thus not submitted in the initial call for abstracts in June (i.e. late-breaking results).
Best regards,
Benedicte CLEMENT
Conference Manager
Heard back from CTAD on presentation title changes his answer:
Dear Sir,
The presenting author revised the title.
Best regards,
Benedicte CLEMENT
Conference Manager
Thank you!
How does the compensation work for that program? Do you receive interest or what? Just curious and isn't that program designed for securities that are hard to borrow? Can you explain a little please. Thanks!
Sorry don't understand that proverb!
Correct I asked this exact question to IR and they replied with a response that Anavex issued a PR stating the title. Now I have reached out to the congressional Secretary of the conference however I have yet to get a response back. I don't expect one back either.
Can you read bro. I said it's all noise.
Missed the first 20 mins of debate but at 10:26 Hillary finally mentioned dealing with pharma companies. Very brief but will most likely cause some panic once again. IMO just noise. Go AVXL!!!
Great more shares for me. Your loss!
I think a offering anytime prior to conference on November might be sending the wrong message to investors. That's why I said if he is smart he does it after results when shares price is through the roof. If he does it before it could steer investors to believe that results might not be as good as expected.
If the good Dr. is smart he will do the offering day after the results are released. I remember back when Kerxy did there offering after releasing positive phase 3 data on Zerenax and the shares never looked back. Opened up morning of at 3.00 and closed three days later or so at 9.99. That's if the results are as we expect. GREAT!
Yea I think you could be right!
Not to damper the mood here but fellas don't you think this thing needs to cool off here a bit. It's been gaining 15-20% each session post reverse split. I know there are a lot of people now excited about the possibilities but this thing is just ignoring gravity. Thoughts?
My question to all you guys and you are one of them that showed up today. Most likely be a out once again tomorrow in forces. So here it is. Now think about this long and hard. Why is it that you guys only seem to post when the stock shoots to the moon? I knew today would be a great day when all you guys showed up last night saying the reverse split was doom and gloom. So explain to me why you guys only show up when she starts to fly?
Yea me too bro that's how I found out about buying and selling must call broker. DTC hasn't approved transfer of shares yet.
As I explained earlier yes this is a problem but if you want to sell just call Scottrade they can place the sale for you. But why sell this is heading to the moon.
No it's right. The volume will be skewed remember this isn't a penny no more!
I don't use Ihub bro! Who is your broker? Scottrade, TD Ameritrade, etc...?
It should be working. AVXLD on level II
Ok I'm getting no volume on level II. However price is increasing but no volume? TD Ameritrade? Nevermind sorry just got volume
Ok thanks bro alot for your help? Do you have alot of problems with Scottrade? My main office for Scottrade is in Miami and they never open on time they never answer the phone so I get transferred to St. Louis and never get deposits deposited in a timely fashion. Horrible customer service. Even though it lately has been better with
new Manager. Thanks again!
Really I hope that is true. Do you have an account with Scottrade now? U own shares of Anavex? Is your info incorrect in your account?
Hess I was apart of that whole debacle and even though they presented results that didn't meet there endpoints the delivering of Stem Cells did in fact beat out the standard of care. So yes they didn't meet there primary endpoints but you didn't tell the whole story. Like they are running another trial reducing the window of time between stroke and getting to the hospital. In fact the Stem Cells did work. Also that study was a blind study. Anavex is open label huge difference.
Please information from this great board would be awesome: Anyone have Scottrade? If so this is the first position I have owned that has done a reverse split to uplist so how long will it take the DTC to approve the transfer of shares so we can actually see the correct information in our accounts? Anyone cause I seriously have had nothing but problems with them since I opened up this corporate account. Thanks guys for your time!
Most recent 8-K
Effective October 1, 2015 (the “Effective Date” ), the Board appointed Sandra Boenisch, to serve as the Company’s Principal Financial Officer. CFO in place at a cost of 78K. Plus bonuses and salary increases. Also benefits!
Picked up more shares @1.55. Another 6k on the books!
We all get it buddy! Your a genius! Market Guru! How do I follow you so I can be BANKING$$$$$$. Your full of SH*T$$$$$$$$
Good job recouping those original losses!
Everytime I read your ridiculous rants afterwards I feel like I have to run and take a shower. Dammit and I just got to office. Yuck! Oh btw I will take that bet. How much?
So you are not getting back in then.
I'm behind on my DD I was busy this weekend so this is the first time I have been able to sit down and do some DD. Definitely interesting but I will see if a call to the CTAD congress secretariat can yield any info into this? I will post my findings if any after I get a response.
Yea hard not to when you are a shareholder? Anyone again notice the title change? obvious IP man didn't please don't reply unless have something of substance to back. I wonder why it was changed? Time to call!
Has anyone noticed that the change in title of presentation?
Old title:
CTAD 2015 Program for Saturday November 7th. 9.45 am OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Clinical Cognitive Improvement observed in Mini Mental State Examination (MMSE) and other Cognitive Markers in a Phase 2a Study in mild-to moderate Alzheimer’s Patients
New Title:OC49 - New Exploratory Alzheimer’s Drug ANAVEX 2-73: Assessment of Safety and Cognitive
Performance in a Phase 2a Study in mild-to-moderate Alzheimer’s Patients
It's been a long day am I missing something?
Margin call?
Specifically if this next go round with data will be of 32 patients or only partial of patients.
Ok well first read the message from IR. Secondly read your last sentence from your post. Here I will copy it for you. "That said, I hope it is the full set plus some from Part B. Now what key words do you draw from both IR 's message and yours? That's right you got it! FULL! Also your thinking of presenting data twice before year end on part A. Highly unlikely. But yes this is my opinion.
How so elaborate?
Well this info from IR confirms all 32 patients will be included in next data set.
Thank you for your email and continued interest in Anavex Life Sciences Corp. (OTCQX: AVXL).
Full PART A data from the Phase 2a trial of ANAVEX 2-73 is expected by year end.
Please do not hesitate to contact our office if we can be of further assistance.
On behalf of Anavex Life Sciences Corp.,
Christine Payne
Primoris Group Inc.
Toll Free (North America): 1 (866) 505-2895
Outside North America: +1 (416) 489 0092
Fax: +1 (416) 352 5239